Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. (vol 48, pg 1685, 2009)

被引：0
|
作者：
Chideya, S.
Winston, C. A.
Peloquin, C. A.
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2009年 / 49卷 / 05期
关键词：
D O I：
10.1086/605407
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 4 条
  • [1] Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV-Infected Cohort of Adults with Tuberculosis from Botswana
    Chideya, Sekai
    Winston, Carla A.
    Peloquin, Charles A.
    Bradford, William Z.
    Hopewell, Philip C.
    Wells, Charles D.
    Reingold, Arthur L.
    Kenyon, Thomas A.
    Moeti, Themba L.
    Tappero, Jordan W.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) : 1685 - 1694
  • [2] Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana
    Sibanda, T.
    Tedla, Z.
    Nyirenda, S.
    Agizew, T.
    Marape, M.
    Miranda, A. G.
    Reuter, H.
    Johnson, J. L.
    Samandari, T.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (02) : 178 - 185
  • [3] Clinical update: Impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin (Reprinted from MMWR, vol 45, pg 921-925, 1996)
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1546 - 1546
  • [4] Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors (Reprinted from MMWR, vol 53, pg 37, 2004)
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (08): : 938 - 938
1